S&u PlcLSE: SUS

Exercise and Sale of Options, Total Voting Rights

· Issued by S&u Plc
RNS Number : 0456Z
S & U PLC
07 January 2020
 

 S & U PLC ("S&U" or "the Company")

Exercise and Sale of Options, Director/PDMR Shareholding and Total Voting Rights

7 January 2020

Exercise and Sale of Options

S&U plc announces that it has today received notice of the exercise of 13,500 options granted to Mr Guy Thompson, a director of S&U plc under the Company's 2010 Long Term Incentive Plan ("LTIP"). These options were exercised at an exercise price of 12.5 pence per share and these 13,500 Ordinary Shares were sold in the market at an average price of 2,100 pence per share. Following these transactions the beneficial shareholding of Mr Guy Thompson is nil ordinary shares and he holds nil vested but unexercised ordinary share options. He also holds 6,000 vested shadow share options and 15,000 unvested shadow share options.

These 13,500 Ordinary Shares were admitted to trading this week pursuant to an existing block listing, and will rank pari pasu with existing Ordinary Shares.

Total Voting Rights

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 12,120,093. This number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FCA's Disclosure and Transparency rules.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Guy Thompson

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

S&U PLC

b)

LEI

213800QZ1X2A7J64SQ31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 12.5p each

ISIN :   GB0007655037

b)

Nature of the transaction

Exercise of options under the Company's 2010 Long Term Incentive Plan

c)

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

12.5p

13,500

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

7 January 2020

f)

Place of the transaction

London Stock Exchange (XLON)

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 12.5p each

ISIN :   GB0007655037

b)

Nature of the transaction

Sale of Ordinary Shares following an exercise of options under the Company's 2010 Long Term Incentive Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date

2,100p

13,500

7 January 2020

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume: 13,500

Volume weighted average price: 2,100p

e)

Date of the transaction

7 January 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Enquiries:

Anthony Coombs

S&U plc

c/c/o Newgate Communications

Financial Public Relations

Bob Huxford, Tom Carnegie, Megan Kovach                        

Newgate Communications    

020 7653 9848

Broker

Adrian Trimmings, Andrew Buchanan, Rishi Shah

Peel Hunt LLP

020 7418 8900


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASFXEFXEEFA